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Summary
Cheddar cheese has been manufactured with Lactobacillus casei Zhang as the dairy
starter adjunct. L. casei Zhang had previously been isolated from koumiss collected from
Xilin Guole in Inner Mongolia and characterized in detail with regard to their probiotic
potential. The addition of L. casei Zhang to Cheddar cheese had no adverse effects on sen-
sory criteria. The cheese made with 0.1, 1 and 2 % of the probiotic strain L. casei Zhang ad-
juncts contained high levels of the Lactobacillus after 6 months of ripening with final counts
of 9.6·107, 7.7·107 and 1.02·108 CFU/g, respectively. In the ripe control cheese, without the
addition of probiotic strain L. casei Zhang, the number of Lactobacillus reached 5.7·107 CFU/g.
Enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) analysis was used to dis-
tinguish the added L. casei Zhang from the natural flora of the cheese and to determine
whether L. casei Zhang grew in the cheese. ACE-inhibitory activity and g-aminobutyric
acid (GABA) concentrations in the cheese were measured. Compared with control cheese,
experimental cheese with 0.1, 1 and 2 % of probiotic strain L. casei Zhang revealed some
increase in ACE-inhibitory activity and GABA mass fraction. In the present study, the pro-
duction of both ACE-inhibitory activity and GABA in the probiotic cheese with the L. casei
Zhang adjunct isolated from koumiss has been found for the first time. The results suggest
that cheese with the probiotic strain L. casei Zhang showed good potential for application
in the management of hypertension.
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Introduction
Probiotics have been defined as live microbial food
supplements that benefit human health. Viable lactic
acid bacteria (LAB) of probiotic foods have several sci-
entifically established and/or clinically proved health ef-
fects, such as reduction and prevention of diarrhoea of
different origin, improvement of the intestinal microbial
balance by antimicrobial activity, alleviation of lactose
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intolerance symptoms, prevention of food allergy, en-
hancement of immune potency, and antitumorigenic acti-
vities (1).
In recent years the consumption of cheese has in-
creased rapidly owing to the fact that this dairy product
fulfils many of the current dietary needs. It is a ready-
-to-eat food, and rich in nutritional components. It has
been reported that Cheddar cheese may offer certain ad-
vantages as a carrier of probiotic microorganisms, hav-
ing a higher pH than the more traditional probiotic
foods (e.g. yogurts and fermented milk). Furthermore,
the matrix of the cheese and its relatively high fat con-
tent may offer protection to probiotic bacteria during
passage through the gastrointestinal tract (2–6).
High blood pressure has been considered as a risk
factor for the development of cardiovascular disease (ar-
teriosclerosis, stroke and myocardial infarction) and end-
-stage renal disease. Angiotensin I-converting enzyme
(ACE; dipeptidyl carboxypeptidase I, EC 3.4.15.1) plays
an important role in the regulation of blood pressure.
ACE inhibitors may exert an antihypertensive effect.
Various lactic acid bacteria produce specific peptides
that possess an inhibitory activity against the ACE in vi-
tro and demonstrate a hypotensive effect in the hyper-
tensive rat model. The g-aminobutyric acid (GABA) is
well known as a neurotransmitter that regulates inhibi-
tory neurotransmission in mammalian central nervous
systems. In addition, GABA has been proved to be effec-
tive for lowering the blood pressure of mammals. Milk
products fermented by lactic acid bacteria enriched with
GABA decreased the blood pressure in spontaneously
hypertensive rats, and in mildly and moderately hyper-
tensive patients (7).
The beneficial health effects of cheese can be en-
hanced by the ACE-inhibitory peptides or GABA pro-
duced during fermentation and storage. More recently, a
great interest in the ACE-inhibitory peptides (8–14) or
GABA (15–18) of cheese has been developed. However,
there are no reports on the development and character-
ization of probiotic Cheddar cheese by koumiss-derived
Lactobacillus, which not only possesses ACE-inhibitory
activity but also can produce GABA.
L. casei Zhang had previously been isolated from kou-
miss collected in Xilin Guole, Inner Mongolia, PR China,
and characterized in detail with regard to their probiotic
potential. The ability to withstand the strict acid and
bile, and remove cholesterol from the growth media in
vitro has been detected. L. casei Zhang showed relatively
high resistance to low pH than other isolated lactobacilli
from koumiss. Previous studies had also shown that L.
casei Zhang was able to enhance natural and acquired
immunity in healthy mice and antagonism to Escherichia
coli in mice as well as the ability to adhere to human in-
testinal epithelial cells (19–23). Soy milk, bovine milk
and mare’s milk could be served as vehicles for delivery
of probiotic L. casei Zhang (24,25). The expression of
H+-ATPase of L. casei Zhang in acid conditions was
studied and the results show that the expression of
H+-ATPase is associated with the acidity of the environ-
ment in L. casei (26). In addition, to understand further
genetic background and functional mechanism of this
strain, we have completed and annotated the whole ge-
nome sequence recently (GenBank Accession No. CP
001084).
This study investigates the performance of the pro-
biotic strain L. casei Zhang added to Cheddar cheese, as
well as the ACE-inhibitory activity and GABA content
in the cheese. A better perspective towards this end
could help the development of the probiotic cheese for
the management of hypertension.
Materials and Methods
Origin and properties of microbial strain
The probiotic strain Lactobacillus casei Zhang had
previously been isolated in our lab from koumiss col-
lected in Xilin Guole in Inner Mongolia, PR China. The
high tolerance of acidic pH and high bile salt by L. casei
Zhang has been demonstrated in in vitro studies. It could
grow well at pH=3.0 and 3 h after artificial gastric juice
digestion, its survival rate was much greater than of
other viable lactic acid bacteria (LAB) tested. The pres-
ence of bile salt hydrolase activity was also noticed in L.
casei Zhang, which was able to catalyze the hydrolyza-
tion of sodium taurocholate in the medium and release
free bile salt. The strain was able to sustain a bile salt
concentration of 1.6 g per 100 mL of the medium (22).
Cheese manufacture
Freeze-dried cheese inoculant R-707 (Chr Hansen,
Wisby, Denmark), containing Lactococcus lactis ssp. lactis
and Lactococcus lactis ssp. cremoris, was used as a starter.
Cheese was made with 10 L of pasteurized (63 °C, 30
min) whole milk. Raw milk was purchased from Yili Com-
pany (Huhhot, PR China) and its composition of the
raw milk was (in %, by mass per volume): total solids
12.25, total proteins 3.02, fat 3.93 and lactose 5.3.
The freeze-dried culture containing 2·1011 CFU/g of
L. casei Zhang was prepared in our laboratory. The heat-
-treated (90 °C for 30 min) 10 % (mass per volume) re-
constituted skimmed milk was inoculated with 1 % (mass
per volume) freeze-dried L. casei Zhang. After inocula-
tion, the skimmed milk was incubated at 37 °C for 24 h.
Then L. casei Zhang suspension (2.43·108 CFU/mL) from
the skimmed milk was added as adjunct into the pas-
teurized cow’s milk (5·102 CFU/mL) at a volume frac-
tion of 0.1, 1 or 2 %, together with 0.5 % (mass per vol-
ume) cheese starter and CaCl2 (25 g per 100 kg) before
rennet (12 g/t of milk) coagulation for 35 min at 35 °C.
The curd was cut into 0.63 to 1.59 cm3 blocks and cooked
to 39 °C. The cooking took only 20–60 min and the curd
was stirred constantly during this step to avoid uneven
cooking or overcooking. Whey was removed from the
curd by allowing it to drain out of the vat. The curd was
allowed to set for a few minutes. By the end of the set-
ting, the acidity of the whey was somewhere between
0.15 and 0.17. Loaves of curd were cut about 15 cm
wide. After 10 min, the loaves were turned and stacking
began. Every 10 min, when the loaves had to be turned,
they were stacked. When the turning process was com-
plete, the loaves were milled into about 1.3-cm pieces.
After all the curd was milled, salt was added at a rate of
2.8 % (by mass), and the curd was placed into the mould
to drain off the whey and was left to ripen at 12 °C for
180 days at a relative air humidity of 85 to 90 %. The
cheese made without probiotic strain L. casei Zhang ad-
ditive was used as a control.
Sensory evaluation of cheese
Cheese samples were graded blindly after 6 months
of ripening by a commercial grader from a local cheese
manufacturing plant for the characteristics of 'flavour'
and 'body', with maximum scores of 45 and 40, respec-
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tively. Minimum scores of 38 and 31 for flavour and
body, respectively, are required for commercial Cheddar
cheese (2).
Determination of ACE-inhibitory activity
Water-soluble extracts (pH=4.6) of each of the cheese
samples were prepared according to the method of Ku-
chroo and Fox (27). The pH of the water-soluble extracts
was adjusted to pH=8.3 with NaOH and then they were
centrifuged at 6000´g for 10 min. Subsequently, the super-
natant was used to determine the ACE-inhibitory activ-
ity and GABA content of the samples.
ACE-inhibitory activity was assayed as described by
Chen et al. (28). A mass of 500 mg of hippuryl-L-histidyl-
-L-leucine (HHL, Sigma-Aldrich China Inc, Shanghai, PR
China) was dissolved in 77.6 mL of 100 mmol/L Na-bo-
rate buffer (pH=8.3) containing 300 mmol/L NaCl. Rab-
bit lung ACE (Sigma-Aldrich China Inc, Shanghai, PR
China) was dissolved in the same buffer at a concentra-
tion of 53.2 mU/mL. A mixture containing 75 mL of ACE
solution and 75 mL of filtered sample (150 mg/mL) was
incubated at 37 °C for 10 min, then 75 mL of HHL solu-
tion were added and incubated for 30 min. The reaction
was stopped by the addition of 250 mL of 1 mol/L HCl.
A volume of 10 mL of this solution was injected directly
into a Luna C18 column (4.6´250 mm, particle size 5 mm;
Phenomenex, Torrance, CA, USA) to separate the prod-
uct and hippuric acid (HA) from HHL. The column was
eluted with 50 % methanol in water (by volume) con-
taining 0.1 % trifluoroacetic acid (TFA) at a flow rate of
0.8 mL/min using a pump and the detector was moni-
tored at 228 nm. The inhibition was calculated from the
equation:
[(Ac–As)/(Ac–Ab)]·100 /1/
where Ac is the absorbance of the buffer (control), As is
the absorbance of the reaction mixture (sample), and Ab
is the absorbance of the blank when stop solution was
added before the reaction occurred.
Determination of g-aminobutyric acid
The determination of GABA was performed by high-
-performance liquid chromatography (HPLC). A volume
of 1 mL of the sample was diluted with 16 % (mass per
volume) trichloroacetic acid (TCA) to 10 mL and shaken
for 30 s. The extract was centrifuged for 10 min at 8000´g.
The supernatant was collected and filtered through a
0.45-mm film (Millipore Express®, Billerica, MA, USA).
Samples were then analyzed using an Agilent 1100 HPLC
with a fluorescence detector (FLD) at excitation l(Ex)=
340 nm and emission l(Em)=450 nm (0–25 min). Separa-
tion was carried out with a Zorbax Eclipse AAA (4.6´
150 mm, 3.5 mm, Agilent Technologies, Santa Clara, CA,
USA). A linear gradient profile of mobile phase, com-
prising 40 mmol/mL Na2HPO4, pH=7.8 (solvent A) and
acetonitrile/methanol/water (45:45:10, by volume (sol-
vent B), 0 % B (0–1.5 min), 0–40 % B (1.5–24.0 min),
40–100 % B (24.0–24.5 min), 100 % B (24.5–29.5 min),
100–0 % B (29.5–30.0 min) and 0 % B (30.0–35.0 min)
was applied at a flow rate of 2.0 mL/min. The column
temperature was kept at 40 °C. Precolumn derivatization
with o-phthalaldehyde (OPA) was used and a 0.5-mL por-
tion was injected into the HPLC system (Agilent Tech-
nologies, Santa Clara, CA, USA).
Chemical analysis
The total solids (gravimetric drying at 98–100 °C),
fat (Rose-Gottlieb method), ash (muffle furnace at 550
°C), and total nitrogen (Kjeldahl method) were deter-
mined according to the Association of Official Analytical
Chemists (AOAC) methods nos. 925.23, 905.02, 945.46
and 991.20, respectively (29). The total protein content
was calculated from total nitrogen using a 6.38 conver-
sion factor.
Microbial analysis of probiotic cheese
The cheese samples were homogenized and serial
dilutions of homogenized cheese were prepared with 0.9
% NaCl solution. After serial dilution with maximum
recovery, total viable count of the Lactobacillus was de-
termined by a pour plate method using Rogosa selective
lactobacillus (RSL) medium (Merck, Damstadt, Germany).
The plates were incubated in anaerobic jar at 37 °C for
48 h.
After six months, 20 individual Lactobacillus colonies
from each cheese were randomly selected from the RSL
agar plates for enterobacterial repetitive intergenic con-
sensus PCR (ERIC-PCR) analysis. Genomic DNA from
Lactobacillus was isolated using Wizard® Genomic DNA
Purification Kit (Promega, WI, USA) according to the
manufacturer’s instructions. PCR was performed using
the upstream primer 5’-ATGTAAGCTCCTGGGATTCAC-
-3’ and the downstream primer 5’-AAGTAAGTGACTG-
GGGTGAGCG-3’ (30). The cycling program was 95 °C
for 7 min, 52 °C for 60 s, 65 °C for 8 min for the first cy-
cle and 90 °C for 30 s, 52 °C for 60 s, 65 °C for 8 min for
the next 35 cycles and one cycle at 65 °C for 16 min. All
PCR amplicons were electrophoresed on 2 % (mass per
volume) agarose gels at a constant voltage of 4 V/cm.
PCR patterns were stained with ethidium bromide (0.5
mg/mL) and visualized under UV light at 254 nm.
Assessment of proteolysis in Cheddar cheese
Urea-PAGE electrophoresis of the cheese samples
was carried out according to the method of Tarakçi et al.
(31). The free amino nitrogen (FAN) content of the sam-
ple was measured by the method of Church et al. (32).
Water-soluble extracts (pH=4.6) of each of the cheese
samples were prepared and water soluble nitrogen (WSN)
was determined according to the method described by
the AOAC method no. 991.20 (29). Results were ex-
pressed as the ratio of WSN or FAN to total nitrogen
(TN) content.
Statistical analysis
All experiments were performed in triplicate. Data
were tested for statistical significance by the Statistical
Analysis System software (SAS v. 9.00, SAS Institute
Inc., NC, USA).
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Results and Discussion
Compositional analysis and sensory evaluation
The comparable values observed for control and ex-
perimental cheese samples indicate that incorporation of
probiotic L. casei Zhang as starter culture, and their sur-
vival at high numbers, had no direct effect on cheese
composition. All cheese samples could be described as
commercial grade with respect to sensory criteria. After
6 months of ripening, probiotic cheese samples achieved
the scores of 39 and 36 for flavour and body, respec-
tively (Table 1). Lactic acid bacteria adjuncts had previ-
ously been reported to improve or decrease cheese fla-
vour. Acceptability of probiotic cheese with L. casei 279
was significantly lower (p<0.05) than that of the control
cheese with bitterness and sour-acid taste as the major
defects after ripening for 9 months at 4 °C. There were
positive correlations (p<0.05) between the scores of bit-
terness and the level of water-soluble nitrogen (33). The
presence of Enterococcus faecium PR88 strain in Cheddar
cheese at levels greater than or equal to 108 CFU/g may
positively influence Cheddar flavour during 9 months
of ripening at 8 °C (34). Slight changes in the gross com-
position and appreciable differences in the flavour pro-
file were observed between control and experimental
cheese samples with Lactobacillus delbrueckii ssp. lactis
UO 004. This strain was capable of surviving at high cell
numbers of 108 to 109 CFU/g in cheese after 28 days of
ripening without adversely affecting sensory criteria or
appearance of the cheese (35).
In this study, laboratory-scale cheese samples with
different levels of L. casei Zhang were found to have the
flavour and body comparable to those of control cheese,
indicating that the addition of L. casei Zhang to Cheddar
cheese had no adverse effects on sensory criteria.
Survival of the strain in cheese
Microbiology of the Cheddar cheese samples after 6
months of ripening and the ERIC-PCR profiles of Lac-
tobacillus isolates from the ripened cheese are shown in
Figs. 1 to 5. Results demonstrate that cheese made with
0.1, 1 or 2 % of probiotic strain L. casei Zhang adjuncts
(Fig. 1) contained high levels of Lactobacillus after 6 months
of ripening, with final counts of 9.6·107, 7.7·107, and
1.02·108 CFU/g, respectively. In the ripe control cheese,
the number of Lactobacillus reached 5.7·107 CFU/g. The
counts of Lactobacillus in all probiotic cheese were signif-
icantly higher than that of the control cheese (p<0.05).
This was confirmed by the comparison with the ERIC-
-PCR fingerprints generated for Lactobacillus isolates from
6-month-ripened cheese. The Lactobacillus isolated from
the cheese with 0.1, 1 and 2 % of probiotic strain L. casei
Zhang (Figs. 2 to 5) were mainly identified by ERIC-
-PCR as L. casei Zhang, while the Lactobacillus isolated
from the control cheese without probiotic strain L. casei
Zhang were identified by ERIC-PCR as non-starter lactic
acid bacteria (NSLAB). Some studies demonstrated that
Cheddar cheese can be an effective vehicle for delivery
of high numbers of probiotic organisms. Cheddar cheese
produced with starter lactococci and Bifidobacterium lon-
gum 1941, B. lactis LAFTI® B94, L. casei 279, L. paracasei
LAFTI® L26, L. acidophilus 4962 or L. acidophilus LAFTI®
L 10 was used to study the survival of the probiotic bac-
teria during ripening period of 6 months at 4 °C. All
probiotic adjuncts survived the manufacturing process of
Cheddar cheese at high levels without alteration of the
cheese-making process. L. acidophilus 4962, L. casei 279,
B. longum 1941, L. acidophilus LAFTI® L10, L. paracasei
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Table 1. Composition and sensory evaluation of control and probiotic Cheddar cheese samples*





A 1.63±0.01 64.63±0.11 34.94±0.38 25.33±0.37 39 36
B 1.62±0.03 64.71±0.18 34.40±0.36 25.37±0.30 39 36
C 1.60±0.01 65.27±0.10 35.25±0.40 25.51±0.20 39 36
Control 1.60±0.02 64.61±0.17 34.97±0.42 25.37±0.64 38 36
*Composition analyses conducted at 14 days; sensory evaluation was conducted at 6 months; control – starter (freeze-dried cheese
inoculant R-707) only was added to the cheese during manufacture, A – 2.0 % probiotic L. casei Zhang was added to the starter cul-
ture during manufacture of cheese as an adjunct, B – 1.0 % probiotic L. casei Zhang was added to the starter culture during manufac-
ture as an adjunct, C – 0.1 % probiotic L. casei Zhang was added to the starter culture during manufacture as an adjunct
amaximum score=45 and minimum commercial score=38, bmaximum score=40 and minimum commercial score=31; data are means
of triplicate determinations±standard deviation
Fig. 1. Survival of lactobacilli of control and probiotic Cheddar
cheese samples ripened at 12 °C for 180 days; data are means
of triplicate determinations±standard deviation; for abbrevia-
tions see Table 1
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Fig. 2. ERIC-PCR-generated DNA fingerprints for Lactobacillus isolates from 6-month-ripened probiotic cheese with 2 % L. casei
Zhang starter adjunct: lane L shows the ERIC-PCR profile of the L. casei Zhang added to the cheese during manufacture, while
DL2000 marker is shown in lane M. All other lanes show ERIC-PCR profiles of Lactobacillus isolates from 6-month-ripened cheese
Fig. 3. ERIC-PCR-generated DNA fingerprints for Lactobacillus isolates from 6-month-ripened probiotic cheese with 1 % L. casei
Zhang starter; for legend see Fig. 2
Fig. 4. ERIC-PCR-generated DNA fingerprints for Lactobacillus isolates from 6-month-ripened probiotic cheese with 0.1 % L. casei
Zhang starter; for legend see Fig. 2
LAFTI® L26 and B. lactis LAFTI® B94 can be applied suc-
cessfully in Cheddar cheese (36). Three batches of Ched-
dar cheese (batch 1, with lactococci as the only starter;
batch 2, with lactococci, L. acidophilus 4962, L. casei 279
and Bifidobacterium longum 1941; and batch 3, with lacto-
cocci, L. acidophilus LAFTI® L10, L. paracasei LAFTI® L26
and B. lactis LAFTI® B94) were manufactured in tri-
plicate to study the survival and influence of probiotic
bacteria on proteolytic patterns. All probiotic adjuncts
survived manufacturing process and maintained their
viability of >7.5 log CFU/g at the end of ripening (37).
Although Lactobacillus has been added to Cheddar
cheese and has subsequently been found to remain at
high levels throughout maturation, no definitive identi-
fication method was used in these studies to distinguish
the added Lactobacillus from the natural flora of the
cheese.
ERIC- and repetitive sequence based (REP)-PCR have
specific advantages compared to other molecular finger-
printing methods. REP elements and ERIC sequences
are dispersed throughout bacterial genomes and PCR
studies confirmed that inter-REP and inter-ERIC dis-
tances or profiles are typical for given bacterial species
and sometimes even for strains within a given species.
However, ERIC- and REP-PCR techniques have so far
not been extensively used for the differentiation of
lactobacillus strains (30). In the present study, ERIC-PCR
analysis, when used as an identification method, deter-
mined that probiotic L. casei Zhang strain grew in the
cheese.
ACE-inhibitory activity and GABA content in
Cheddar cheese
Compared with control cheese, experimental cheese
with 0.1, 1 and 2 % of probiotic strain L. casei Zhang re-
vealed some increase in ACE-inhibitory activity and
GABA content. The basic values of the ACE-inhibitory
activity and GABA content of Cheddar cheeses are de-
scribed in Table 2. The ACE-inhibitory activity in the
control cheese was 60.13 %, while in the experimental
cheese with 0.1, 1 and 2 % of probiotic strain L. casei
Zhang the ACE-inhibitory activity was recorded as 91.45,
85.30 and 100 %, respectively.
Some ACE-inhibitory peptides have been reported
in the cheese. Cheddar cheese samples made with the
addition of L. casei 279, L. casei LAFTI® L26 or L. acido-
philus LAFTI® L10 had significantly higher (p<0.05) ACE-
-inhibitory activity than those without any probiotic ad-
junct (13). The high ACE-inhibitory activity found in the
water-soluble extracts of some investigated hard cheese
samples was mainly due to the presence of Val-Pro-Pro
(VPP) and Ile-Pro-Pro (IPP) (12).
The level of GABA in the control cheese was 238.49
mg/kg, while in the experimental cheese with 0.1, 1 and
2 % of probiotic strain L. casei Zhang it was 525.34,
538.11 and 677.35 mg/kg, respectively.
Several GABA-producing lactic acid bacteria have
been identified, including Lactobacillus paracasei isolated
from a Japanese traditional fermented fish, Lactobacillus
brevis isolated from kimuchi and alcohol distillery lees,
and Lactococcus lactis from cheese starters (38). It has been
reported that the mass fractions of GABA in 22 Italian
cheese varieties that differ in several technological traits
markedly varied from 0.26 to 391 mg/kg. Lactobacillus
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Fig. 5. ERIC-PCR-generated DNA fingerprints for Lactobacillus isolates from 6-month-ripened control cheese without the L. casei
Zhang starter; for legend see Fig. 2











a, b, c, dMeans with different superscripts in the same row differ
significantly (p<0.01); data are means of triplicate determina-
tions±standard deviation; for abbreviations see Table 1
paracasei PF6, Lactobacillus delbrueckii ssp. bulgaricus PR1,
Lactococcus lactis PU1, Lactobacillus plantarum C48 and
Lactobacillus brevis PM17 were the best GABA-producing
strains during fermentation of reconstituted skimmed
milk (18).
In this study, the GABA content could be enhanced
by applying L. casei Zhang in the cheese. The findings of
this study provide a potential to develop health-promot-
ing probiotic L. casei Zhang cheese enriched with GABA.
GABA-producing lactic acid bacteria which rapidly
produced a large amount of GABA from glutamic acid
(Glu) by glutamate decarboxylase (GAD) [EC 4.1.1.15]
were also isolated. In the case of L. brevis, 4 of the 8
strains tested produced GABA, with the production of
50 mmol/L of GABA from 59 mmol/L of Glu in the glu-
cose yeast extract polypepton medium (39). However,
the high cost of the culture medium remains a problem
for the commercial production. It seems that an econom-
ical and simple process of natural GABA production
without Glu supplementation could be achieved by the
probiotic cheese with the addition of L. casei Zhang. It
has been reported that GABA can facilitate cell survival
by maintaining cellular pH, even under acidic environ-
ments, because GAD must consume an H+ ion for GABA
production. Similarly, dairy products with high GABA
and GAD activity are capable of sustaining probiotics
through the digestive system, by which they made it
possible to have probiotic effects, and also they may
possess the same acid stability properties that are re-
quired to survive in the intestines (40). The GABA-en-
riched milk (1 nmol/mL) was reported to lower the
blood pressure in spontaneously hypertensive and nor-
motensive Wistar-Kyoto rats (41). Therefore, the amount
of GABA in the probiotic cheese made with L. casei
Zhang adjunct is high enough to have some functional
value.
Limited scientific data are available on the ACE-in-
hibitory activity and GABA concentration in cheese in-
oculated with Lactobacillus isolated from koumiss. The
Lactobacillus species in koumiss include L. delbrueckii, L.
acidophilus, L. casei, L. rhamnosus, L. paracasei, L. kefir, L.
salivarius, L. buchneri, L. plantarum (42). In the present
study, the production of both ACE-inhibitory activity
and GABA in the probiotic cheese with L. casei Zhang
isolated from koumiss have been found for the first
time. Cheese already possesses a healthy image and has
a long history of safe production. The production of
both ACE-inhibitory activity and GABA in situ is an ap-
pealing approach, as it adds an additional health effect
to the products.
Proteolysis in Cheddar cheese
Urea-PAGE patterns of whole cheese samples after 6
months of ripening did not show any differences in the
extent of primary proteolysis between the control cheese
and those manufactured with the addition of L. casei
Zhang (Fig. 6). Similarly, others have shown that the ad-
dition of lactobacilli had no effect on PAGE electropho-
retograms (2).
The ratio of WSN and FAN to TN in whole cheese
samples increased progressively throughout the 180 days
of ripening period. No significant differences in the con-
centration of WSN and FAN could be detected in whole
cheese samples (Figs. 7 and 8).
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Fig. 6. Urea-PAGE patterns of Cheddar cheese with 2 % L. casei Zhang starter (lanes 2–9), 1 % L. casei Zhang starter (lanes 10–17), 0.1 % L.
casei Zhang starter (lanes 18–25), without the L. casei Zhang starter (lanes 26–33) for 1, 15, 30, 60, 90, 120, 150 and 180 days, respectively.
The standard casein is shown in lane 1
Fig. 7. WSN/TN analysis of Cheddar cheese during 180 days of
ripening at 12 °C; TN=total nitrogen, WSN=water soluble nitro-
gen; data are means of triplicate determinations±standard devia-
tion; for abbreviations see Table 1
Conclusions
Cheddar cheese was manufactured with Lactobacil-
lus casei (L. casei) Zhang as the dairy starter adjunct. The
addition of L. casei Zhang to Cheddar cheese had no ad-
verse effects on sensory criteria and contained high levels
of Lactobacillus. ERIC-PCR analysis confirmed that pro-
biotic L. casei Zhang strain grew in the cheese. The ex-
perimental cheese with 0.1, 1 and 2 % of probiotic strain
L. casei Zhang revealed some increase in ACE-inhibitory
activity and GABA content. The cheese containing the
probiotic strain L. casei Zhang showed good potential
for application in the management of hypertension.
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